Welcome to our dedicated page for Dynatronics news (Ticker: DYNT), a resource for investors and traders seeking the latest updates and insights on Dynatronics stock.
Dynatronics Corporation (DYNT) is a medical device company that has focused on restorative products for physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Company news has highlighted its role as a manufacturer serving clinical and athletic training environments, with products marketed under brands such as Bird & Cronin®, Solaris™, Hausmann®, Physician's Choice®, and PROTEAM™.
News releases for Dynatronics have covered several recurring themes. Earnings announcements and quarterly financial results provide updates on net sales, gross profit margins, operating performance, and guidance for future fiscal periods. Management commentary in these releases has discussed sales goals, operating plans, and strategic priorities, including product development and business optimization efforts.
Dynatronics’ news flow has also included product and portfolio updates, such as references to new additions to its rehabilitation furniture line, which the company associates with treatment furniture and athletic training center products. Corporate governance and leadership changes have been another focus, with announcements about board appointments and executive hires, including changes in the chief financial officer role and additions to the Board of Directors.
Trading and listing developments have been an important part of Dynatronics’ public communications. In June 2024, the company announced that it had received notice from The Nasdaq Stock Market regarding suspension of trading due to minimum bid price noncompliance and that it would transition its common stock quotation to the OTCQB Venture Market. Later, in January 2026, an 8-K reported that Dynatronics and its subsidiaries ceased operations and filed for Chapter 7 bankruptcy, marking a significant change in the company’s status.
Investors and researchers using this news page can review historical press releases and related coverage to understand Dynatronics’ business focus, financial performance, leadership changes, trading venue transition, and its subsequent Chapter 7 bankruptcy filing.
Dynatronics (NASDAQ: DYNT) announced its transition to the OTC Markets Group due to noncompliance with Nasdaq's minimum bid price requirement. The company received notice of impending delisting from Nasdaq effective July 9, 2024. Consequently, Dynatronics' common stock will be quoted on the OTCQB Venture Market immediately following the delisting. The ticker symbol and CUSIP will remain unchanged, and shareholders need not take any action. Despite the transition, Dynatronics will continue its business operations and remain a reporting company under the Securities Exchange Act of 1934.
Dynatronics , a leading manufacturer of athletic training, physical therapy, and rehabilitation products, reported financial results for its third quarter of fiscal year 2024. The CEO highlighted progress in sales goals and positive EBITDA. New product lines were introduced to enhance sales. Key financial results include total net sales of $7.7 million, a gross profit margin of 23.7%, and a net loss attributable to common stockholders of $0.9 million. The company provided guidance for fiscal year 2024, estimating net revenue to be $32.5 million to $34 million, with ongoing volatility expected due to economic challenges. Dynatronics will hold a conference call to review its third quarter results.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Dynatronics (DYNT)?
What is the market cap of Dynatronics (DYNT)?
